Sign in
CMND Stock Price, Chart, Stats & News
Clearmind Medicine Inc.
Save
Clearmind Medicine Inc. (CMND) does not currently pay a dividend.
1.19M
Market cap
–
Current P/E
–
Forward P/E
CMND chart
Fundamentals
Gross margin | – |
Operating margin | – |
Pretax margin | – |
Net margin | – |
Effective tax rate | -0.53% |
ROA | -59.95% |
ROE | -207.66% |
D/E | 0.00x |
Interest coverage ratio | -369.99x |
CMND valuation
P/E | – |
P/S | – |
P/B | 0.12x |
P/CF | -0.17x |
P/FCF | -0.02x |
P/OCF | -0.17x |
PEG | -0.00x |
EV multiple | -1.47x |
About
Clearmind Medicine Inc. is a pre-clinical biopharmaceutical company dedicated to pioneering the development of novel psychedelic-based treatments. Their primary goal is to address a variety of mental health and addiction challenges that currently lack adequate solutions. The company's research targets conditions such as alcohol use disorder (including problematic binge drinking), various eating disorders (like binge eating), depression, and other compulsive or "binge" behaviors.
Similar securities
Based on sector and market capitalization
Report issue